PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

amikacin vs cefpodoxime

Side-by-side comparison of amikacin and cefpodoxime Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
amikacin Aminoglycoside Antibiotic
cefpodoxime Third-Generation Cephalosporin
Type
amikacin Prescription
cefpodoxime Prescription
Summary
amikacin

Amikacin is an antibiotic medicine. It fights serious infections caused by certain types of bacteria.

cefpodoxime

Cefpodoxime is an antibiotic that fights bacterial infections. It belongs to a class of drugs called cephalosporins.

What It Treats
amikacin

Amikacin treats serious infections caused by bacteria. This includes infections in the blood, lungs, bones, joints, brain, skin, and abdomen. It can also treat burns, post-surgery infections, and complicated urinary tract infections.

cefpodoxime

Cefpodoxime treats mild to moderate infections caused by certain bacteria. It can treat ear infections, throat infections like strep, pneumonia, bronchitis, gonorrhea, skin infections, sinus infections, and bladder infections. Your doctor will decide if cefpodoxime is the right medicine for your infection.

How It Works
amikacin

Amikacin belongs to a class of drugs called aminoglycosides. It works by stopping the growth of bacteria. This helps your body fight off the infection.

cefpodoxime

Cefpodoxime works by stopping the growth of bacteria. It prevents bacteria from forming the cell walls they need to survive. This kills the bacteria and helps your body fight off the infection.

Common Side Effects
amikacin

No common side effects listed.

cefpodoxime
  • Diarrhea
  • Nausea
  • Vaginal fungal infections
  • Vulvovaginal infections
  • Abdominal pain
FAERS Reports
amikacin
  • Off Label Use 1,908
  • Drug Ineffective 1,673
  • Cough 1,620
  • Dyspnoea 1,556
  • Hospitalisation 1,360
cefpodoxime

No adverse event reports.

Serious Warnings
amikacin

Amikacin can potentially cause hearing loss and kidney damage. Tell your doctor if you have kidney problems or are taking other medicines that can affect your hearing or kidneys. Your doctor should closely monitor you for hearing and kidney problems during treatment. This drug can also cause muscle weakness or breathing problems, especially if you are also taking anesthesia or certain muscle relaxants.

cefpodoxime

You should not take cefpodoxime if you are allergic to cefpodoxime or other cephalosporin antibiotics.

Pregnancy
amikacin

Tell your doctor if you are pregnant or breastfeeding. Amikacin may harm your unborn baby. It is not known if amikacin passes into breast milk.

cefpodoxime

Tell your doctor if you are pregnant or breastfeeding before taking this medicine. It is not known if cefpodoxime will harm your unborn baby. Talk to your doctor about the risks and benefits.

Also Compare — Nearby Drugs

How to Read This amikacin vs cefpodoxime Comparison

amikacin is classified in the Aminoglycoside Antibiotic drug class, while cefpodoxime sits within the Third-Generation Cephalosporin class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, amikacin has 8,117 submissions while cefpodoxime has 0. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between amikacin and cefpodoxime — always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.